Literature DB >> 32531442

Automated quantification and architectural pattern detection of hepatic fibrosis in NAFLD.

Samer Gawrieh1, Deepak Sethunath2, Oscar W Cummings3, David E Kleiner4, Raj Vuppalanchi5, Naga Chalasani5, Mihran Tuceryan2.   

Abstract

Accurate detection and quantification of hepatic fibrosis remain essential for assessing the severity of non-alcoholic fatty liver disease (NAFLD) and its response to therapy in clinical practice and research studies. Our aim was to develop an integrated artificial intelligence-based automated tool to detect and quantify hepatic fibrosis and assess its architectural pattern in NAFLD liver biopsies. Digital images of the trichrome-stained slides of liver biopsies from patients with NAFLD and different severity of fibrosis were used. Two expert liver pathologists semi-quantitatively assessed the severity of fibrosis in these biopsies and using a web applet provided a total of 987 annotations of different fibrosis types for developing, training and testing supervised machine learning models to detect fibrosis. The collagen proportionate area (CPA) was measured and correlated with each of the pathologists semi-quantitative fibrosis scores. Models were created and tested to detect each of six potential fibrosis patterns. There was good to excellent correlation between CPA and the pathologist score of fibrosis stage. The coefficient of determination (R2) of automated CPA with the pathologist stages ranged from 0.60 to 0.86. There was considerable overlap in the calculated CPA across different fibrosis stages. For identification of fibrosis patterns, the models areas under the receiver operator curve were 78.6% for detection of periportal fibrosis, 83.3% for pericellular fibrosis, 86.4% for portal fibrosis and >90% for detection of normal fibrosis, bridging fibrosis, and presence of nodule/cirrhosis. In conclusion, an integrated automated tool could accurately quantify hepatic fibrosis and determine its architectural patterns in NAFLD liver biopsies.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Artificial intelligence; Automation; Digital image analysis; NASH

Mesh:

Substances:

Year:  2020        PMID: 32531442     DOI: 10.1016/j.anndiagpath.2020.151518

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  8 in total

Review 1.  Liver fibrosis quantification.

Authors:  Sudhakar K Venkatesh; Michael S Torbenson
Journal:  Abdom Radiol (NY)       Date:  2022-01-12

2.  Diagnosing the Stage of Hepatitis C Using Machine Learning.

Authors:  Muhammad Bilal Butt; Majed Alfayad; Shazia Saqib; M A Khan; Munir Ahmad; Muhammad Adnan Khan; Nouh Sabri Elmitwally
Journal:  J Healthc Eng       Date:  2021-12-10       Impact factor: 2.682

Review 3.  Artificial Intelligence in hepatology, liver surgery and transplantation: Emerging applications and frontiers of research.

Authors:  Fadl H Veerankutty; Govind Jayan; Manish Kumar Yadav; Krishnan Sarojam Manoj; Abhishek Yadav; Sindhu Radha Sadasivan Nair; T U Shabeerali; Varghese Yeldho; Madhu Sasidharan; Shiraz Ahmad Rather
Journal:  World J Hepatol       Date:  2021-12-27

Review 4.  Artificial intelligence in liver diseases: Improving diagnostics, prognostics and response prediction.

Authors:  David Nam; Julius Chapiro; Valerie Paradis; Tobias Paul Seraphin; Jakob Nikolas Kather
Journal:  JHEP Rep       Date:  2022-02-02

Review 5.  Clinical Applications of Artificial Intelligence-An Updated Overview.

Authors:  Ștefan Busnatu; Adelina-Gabriela Niculescu; Alexandra Bolocan; George E D Petrescu; Dan Nicolae Păduraru; Iulian Năstasă; Mircea Lupușoru; Marius Geantă; Octavian Andronic; Alexandru Mihai Grumezescu; Henrique Martins
Journal:  J Clin Med       Date:  2022-04-18       Impact factor: 4.964

6.  Developing a New qFIBS Model Assessing Histological Features in Pediatric Patients With Non-alcoholic Steatohepatitis.

Authors:  Feng Liu; Lai Wei; Wei Qiang Leow; Shu-Hong Liu; Ya-Yun Ren; Xiao-Xiao Wang; Xiao-He Li; Hui-Ying Rao; Rui Huang; Nan Wu; Aileen Wee; Jing-Min Zhao
Journal:  Front Med (Lausanne)       Date:  2022-06-27

Review 7.  Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders.

Authors:  Alexandros Marios Sofias; Federica De Lorenzi; Quim Peña; Armin Azadkhah Shalmani; Mihael Vucur; Jiong-Wei Wang; Fabian Kiessling; Yang Shi; Lorena Consolino; Gert Storm; Twan Lammers
Journal:  Adv Drug Deliv Rev       Date:  2021-06-15       Impact factor: 15.470

Review 8.  Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective.

Authors:  Gwyneth Soon; Aileen Wee
Journal:  Clin Mol Hepatol       Date:  2020-11-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.